back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-09-05 12:57 Tx date 2023-08-31 |
$CTX
Crescita Therapeutics Inc. |
Lafortune, François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,147
+13,860 vol $0.66 each |
126,720 | |
| Filed 2023-06-25 23:01 Tx date 2023-06-20 |
$CTX
Crescita Therapeutics Inc. |
Lafortune, François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,009
+13,860 vol $0.65 each |
112,860 | |
| Filed 2022-01-05 11:58 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Lafortune, François
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+24,000 vol |
24,000 | |
| Filed 2022-01-05 11:56 Tx date 2021-05-10 |
$CTX
Crescita Therapeutics Inc. |
Lafortune, François
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-01-05 11:23 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Lafortune, François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,000 vol |
99,000 | |
| Filed 2021-12-16 12:44 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Lafortune, François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,500
+75,000 vol $0.62 each |
75,000 | |
| Filed 2021-12-16 12:41 Tx date 2021-05-10 |
$CTX
Crescita Therapeutics Inc. |
Lafortune, François
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|